UNFPA saves over $750K in 2015 by increasing use of quality assured generic contraceptives

10 March 2016

The UNFPA Expert Review Panel has played a paramount role in the development of the WHO prequalified base of reproductive health (RH) medicines. The landscape of quality generic (RH) medicines has changed significantly in the past 6 years. Increasing not only quantitative but also qualitative in terms of expanding to cover the different categories.

The increase on the number of generic RH medicines complying with the internationally recognized quality standards applied by UNFPA has a positive impact on prices. This reports shows the savings gained in 2015 from purchasing generic RH medicines.

In 2016, UNFPA plans to continue advocating for the use of generics in order to increase access to RH medicines and to demonstrate true value for money.

Download the full report.

Related content

WHO/UNFPA prequalification programme for male condoms
UNFPA compiles annual statistics on all procurement performed by UNFPA's programs and partners.
The Request for Proposal is for identification of support for a range of WHO prequalification activities.